Biotech IPO activity increases by 15% in Q3 2026 vs Q2 2026

Odyssey's successful IPO could encourage more biotech firms to go public, reflecting improving market conditions. A 15% increase in IPO activity would validate the sector's recovery and investor appetite.

Implied probability (Yes)

65%